Niopas I, Toon S, Rowland M
Department of Pharmacy, Aristotle University of Thessaloniki, Greece.
Br J Clin Pharmacol. 1991 Oct;32(4):508-11. doi: 10.1111/j.1365-2125.1991.tb03940.x.
The urinary profile of R- and S-warfarin, following administration of a single (25 mg) oral dose of racemic warfarin, alone or on day 4 of a 9-day chronic administration of cimetidine (800 mg once daily), was investigated in eight healthy male volunteers. Based on estimated apparent formation clearance values, cimetidine inhibited significantly only the formation of R-6-hydroxywarfarin and R-7-hydroxywarfarin.
在8名健康男性志愿者中,研究了单剂量口服消旋华法林(25毫克)后,单独使用或在西咪替丁(每日一次,800毫克)9天慢性给药的第4天使用时,R-和S-华法林的尿液情况。根据估计的表观形成清除率值,西咪替丁仅显著抑制R-6-羟基华法林和R-7-羟基华法林的形成。